Varicella vaccination
Letter to the Editor Editor, – Before the universal varicella vaccination program, 95% of adults in the USA experienced natural chickenpox (usually as school-aged children). .4 A recent study found a 90% overall increase in adult shingles, from 2.77/1000 to 5.25/1000, during a period of increasing v...
Gespeichert in:
| Veröffentlicht in: | Australian prescriber 2007-10, Vol.30 (5), p.116 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 5 |
| container_start_page | 116 |
| container_title | Australian prescriber |
| container_volume | 30 |
| creator | Goldman, Gary S |
| description | Letter to the Editor Editor, – Before the universal varicella vaccination program, 95% of adults in the USA experienced natural chickenpox (usually as school-aged children). .4 A recent study found a 90% overall increase in adult shingles, from 2.77/1000 to 5.25/1000, during a period of increasing varicella vaccine coverage, 1998-2003.5 If the outcomes in this and other UK studies are due to an immunologically-mediated link (that is, low varicella incidence produces an increase in the incidence of herpes zoster), then the approximate 50% reduction in risk of herpes zoster achieved in a large trial of a zoster virus vaccine, at best reduces shingles incidence back to the prelicensure rate. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. |
| doi_str_mv | 10.18773/austprescr.2007.071 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2680226282</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2680226282</sourcerecordid><originalsourceid>FETCH-LOGICAL-p183t-d98ba59cf08f844147fc37639df72f9f0dd50297db35c0f69690cb51f2c5015f3</originalsourceid><addsrcrecordid>eNotzbFLxDAUgPEgCtbT0c1BcE59eWmSl1EOPYUDF3U90qQPepS2Jq1_vwc6fdvvE-JOQa3IOf0Y1rLMuSsx1wjganDqTFSKtJfaN3guKtAKJQHQpbgq5QiAYIytxO1XyH3shiHc_4QY-zEs_TReiwsOQ-lu_rsRny_PH9tXuX_fvW2f9nI-2YtMntpgfGQgpqZRjeOondU-sUP2DCkZQO9Sq00Ett56iK1RjNGAMqw34uHPnfP0vXZlORynNY-n5QEtAaJFQv0L91w-Fw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2680226282</pqid></control><display><type>article</type><title>Varicella vaccination</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Goldman, Gary S</creator><creatorcontrib>Goldman, Gary S</creatorcontrib><description>Letter to the Editor Editor, – Before the universal varicella vaccination program, 95% of adults in the USA experienced natural chickenpox (usually as school-aged children). .4 A recent study found a 90% overall increase in adult shingles, from 2.77/1000 to 5.25/1000, during a period of increasing varicella vaccine coverage, 1998-2003.5 If the outcomes in this and other UK studies are due to an immunologically-mediated link (that is, low varicella incidence produces an increase in the incidence of herpes zoster), then the approximate 50% reduction in risk of herpes zoster achieved in a large trial of a zoster virus vaccine, at best reduces shingles incidence back to the prelicensure rate. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003.</description><identifier>ISSN: 0312-8008</identifier><identifier>EISSN: 1839-3942</identifier><identifier>DOI: 10.18773/austprescr.2007.071</identifier><language>eng</language><publisher>Melbourne: Therapeutic Guidelines Limited</publisher><subject>Adults ; Chicken pox ; Committees ; Vaccines</subject><ispartof>Australian prescriber, 2007-10, Vol.30 (5), p.116</ispartof><rights>2007. This work is licensed under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids></links><search><creatorcontrib>Goldman, Gary S</creatorcontrib><title>Varicella vaccination</title><title>Australian prescriber</title><description>Letter to the Editor Editor, – Before the universal varicella vaccination program, 95% of adults in the USA experienced natural chickenpox (usually as school-aged children). .4 A recent study found a 90% overall increase in adult shingles, from 2.77/1000 to 5.25/1000, during a period of increasing varicella vaccine coverage, 1998-2003.5 If the outcomes in this and other UK studies are due to an immunologically-mediated link (that is, low varicella incidence produces an increase in the incidence of herpes zoster), then the approximate 50% reduction in risk of herpes zoster achieved in a large trial of a zoster virus vaccine, at best reduces shingles incidence back to the prelicensure rate. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003.</description><subject>Adults</subject><subject>Chicken pox</subject><subject>Committees</subject><subject>Vaccines</subject><issn>0312-8008</issn><issn>1839-3942</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNotzbFLxDAUgPEgCtbT0c1BcE59eWmSl1EOPYUDF3U90qQPepS2Jq1_vwc6fdvvE-JOQa3IOf0Y1rLMuSsx1wjganDqTFSKtJfaN3guKtAKJQHQpbgq5QiAYIytxO1XyH3shiHc_4QY-zEs_TReiwsOQ-lu_rsRny_PH9tXuX_fvW2f9nI-2YtMntpgfGQgpqZRjeOondU-sUP2DCkZQO9Sq00Ett56iK1RjNGAMqw34uHPnfP0vXZlORynNY-n5QEtAaJFQv0L91w-Fw</recordid><startdate>20071001</startdate><enddate>20071001</enddate><creator>Goldman, Gary S</creator><general>Therapeutic Guidelines Limited</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20071001</creationdate><title>Varicella vaccination</title><author>Goldman, Gary S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p183t-d98ba59cf08f844147fc37639df72f9f0dd50297db35c0f69690cb51f2c5015f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adults</topic><topic>Chicken pox</topic><topic>Committees</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Goldman, Gary S</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Australian prescriber</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Goldman, Gary S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Varicella vaccination</atitle><jtitle>Australian prescriber</jtitle><date>2007-10-01</date><risdate>2007</risdate><volume>30</volume><issue>5</issue><spage>116</spage><pages>116-</pages><issn>0312-8008</issn><eissn>1839-3942</eissn><abstract>Letter to the Editor Editor, – Before the universal varicella vaccination program, 95% of adults in the USA experienced natural chickenpox (usually as school-aged children). .4 A recent study found a 90% overall increase in adult shingles, from 2.77/1000 to 5.25/1000, during a period of increasing varicella vaccine coverage, 1998-2003.5 If the outcomes in this and other UK studies are due to an immunologically-mediated link (that is, low varicella incidence produces an increase in the incidence of herpes zoster), then the approximate 50% reduction in risk of herpes zoster achieved in a large trial of a zoster virus vaccine, at best reduces shingles incidence back to the prelicensure rate. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003.</abstract><cop>Melbourne</cop><pub>Therapeutic Guidelines Limited</pub><doi>10.18773/austprescr.2007.071</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0312-8008 |
| ispartof | Australian prescriber, 2007-10, Vol.30 (5), p.116 |
| issn | 0312-8008 1839-3942 |
| language | eng |
| recordid | cdi_proquest_journals_2680226282 |
| source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Adults Chicken pox Committees Vaccines |
| title | Varicella vaccination |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T03%3A55%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Varicella%20vaccination&rft.jtitle=Australian%20prescriber&rft.au=Goldman,%20Gary%20S&rft.date=2007-10-01&rft.volume=30&rft.issue=5&rft.spage=116&rft.pages=116-&rft.issn=0312-8008&rft.eissn=1839-3942&rft_id=info:doi/10.18773/austprescr.2007.071&rft_dat=%3Cproquest%3E2680226282%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2680226282&rft_id=info:pmid/&rfr_iscdi=true |